SCHEMBL3715533

SCHEMBL3715533

CCCc1cc(=O)c2ccccc2o1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARG P37231 3/20 0.69
CYP11B1 P15538 2/20 0.55
CYP11B2 P19099 2/20 0.55
STS P08842 1/20 0.55
ALOX15 P16050 1/20 0.52
MAOB P27338 2/20 0.51
SIGMAR1 Q99720 2/20 0.51
TNKS O95271 2/20 0.49
PARP1 P09874 2/20 0.49
TNKS2 Q9H2K2 2/20 0.49
HPGD P15428 2/20 0.49
NPC1 O15118 2/20 0.49
PLA2G2A P14555 1/20 0.49
PLA2G4A P47712 1/20 0.49
GABRP O00591 1/20 0.49
GABRD O14764 1/20 0.49
CA12 O43570 1/20 0.49
CA1 P00915 1/20 0.49
CA2 P00918 1/20 0.49
TP53 P04637 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30694898 1.00 PPARG (0.69) PPARGCYP11B1CYP11B2STSALOX15
SCHEMBL3660694 0.90 PPARG (0.65) PPARGCYP11B1CYP11B2STSALOX15
SCHEMBL3662892 0.89 ALOX15 (0.68) PPARGCYP11B1CYP11B2STSALOX15
SCHEMBL28050777 0.87 ALOX15 (0.66) PPARGCYP11B1CYP11B2STSALOX15
SCHEMBL3657376 0.87 ALOX15 (0.66) PPARGCYP11B1CYP11B2STSALOX15
SCHEMBL3654554 0.87 ALOX15 (0.66) PPARGCYP11B1CYP11B2STSALOX15
SCHEMBL16893235 0.87 ALOX15 (0.66) PPARGCYP11B1CYP11B2STSALOX15
SCHEMBL3660146 0.87 ALOX15 (0.66) PPARGCYP11B1CYP11B2STSALOX15
SCHEMBL21166318 0.87 ALOX15 (0.66) PPARGCYP11B1CYP11B2STSALOX15
SCHEMBL30876965 0.86 PPARG (0.63) PPARGCYP11B1CYP11B2MAOBSIGMAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118994079-A Method for synthesizing chromone, 1-thiochromone and gamma-pyrone compounds 中国科学院上海药物研究所 2024-11-22 CN disclosed
EP-3841211-A1 METHODS FOR MANUFACTURING PLANT MESSENGER PACKS Flagship Pioneering Innovations VI, LLC (US) 2021-06-30 EP disclosed
WO-2020041784-A1 METHODS FOR MANUFACTURING PLANT MESSENGER PACKS FLAGSHIP PIONEERING INNOVATIONS VI, LLC. (US) 2020-02-27 WO disclosed
US-9844220-B2 Synergistic fungicidal active substance combinations FMC CORPORATION (US) 2017-12-19 US disclosed
US-20160150785-A1 Synergistic Fungicidal Active Substance Combinations BAYER INTELLECTUAL PROPERTY GMBH (DE) 2016-06-02 US disclosed
US-9288988-B2 Synergistic fungicidal active substance combinations FMC CORPORATION (US) 2016-03-22 US disclosed
US-9049867-B2 Synergistic fungicidal active substance combinations BAYER INTELLECTUAL PROPERTY GMBH (DE) 2015-06-09 US disclosed
US-9006143-B2 Synergistic fungicidal active substance combinations BAYER INTELLECTUAL PROPERTY GMBH (DE) 2015-04-14 US disclosed
WO-2014079724-A1 PESTICIDAL MIXTURES BASF SE (DE) 2014-05-30 WO disclosed
US-20130196981-A1 Synergistic Fungicidal Active Substance Combinations BAYER INTELLECTUAL PROPERTY GMBH (DE) 2013-08-01 US disclosed
WO-1997017347-A1 COMPOUNDS DERIVED FROM OXAZOLIDIN-2-ONE AND PREPARATION AND THERAPEUTICAL USE THEREOF SYNTHELABO (FR) 1997-05-15 WO disclosed
EP-0441852-B1 MUSCARINIC RECEPTOR ANTAGONISTS PFIZER LTD (GB) 1997-05-14 EP disclosed
US-5422358-A Muscarinic receptor antagonists PFIZER INC (US) 1995-06-06 US disclosed
EP-0441852-A1 MUSCARINIC RECEPTOR ANTAGONISTS. PFIZER LTD (GB) 1991-08-21 EP disclosed
EP-0376358-A1 Muscarinic receptor antagonists PFIZER INC. (US) 1990-07-04 EP disclosed
WO-1990005133-A1 MUSCARINIC RECEPTOR ANTAGONISTS PFIZER LIMITED (GB) 1990-05-17 WO disclosed
EP-0144729-B1 11-Substituted 5H,11H-pyrrolo[2,1-c][1,4]benzoxazepines, a process for their preparation and their use in medicaments HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) 1989-11-08 EP disclosed
US-4681879-A 11-substituted 5H,11H-pyrrolo[2,1-c][1,4]benzoxazepines as antipsychotic and analgesic agents HOECHST-ROUSSEL PHARMACEUTICALS INC. (US) 1987-07-21 US disclosed
US-4608374-A 11-substituted 5H,11H-pyrrolo[2,1-c][1,4]benzoxazepines as antipsychotic and analgesic agents HOECHST-ROUSSEL PHARMACEUTICALS INC. (US) 1986-08-26 US disclosed
EP-0144729-A1 11-Substituted 5H,11H-pyrrolo[2,1-c][1,4]benzoxazepines, a process for their preparation and their use in medicaments HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) 1985-06-19 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160150785-A1 Synergistic Fungicidal Active Substance Combinations CYP1A2, CAT, CYP51A1 PPARG 2611/4885CYP11B1 362/4885CYP11B2 203/4885
US-20130196981-A1 Synergistic Fungicidal Active Substance Combinations CYP51A1, CYP1A2, CYP4X1 PPARG 2802/4885CYP11B1 278/4885CYP11B2 175/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.